X-155063983-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001018024.3(CMC4):āc.41T>Cā(p.Ile14Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000268 in 1,195,514 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000071 ( 0 hom., 3 hem., cov: 23)
Exomes š: 0.000022 ( 0 hom. 9 hem. )
Consequence
CMC4
NM_001018024.3 missense
NM_001018024.3 missense
Scores
6
6
4
Clinical Significance
Conservation
PhyloP100: 6.75
Genes affected
CMC4 (HGNC:35428): (C-X9-C motif containing 4) This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the downstream 8 kDa protein that localizes to mitochondria.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMC4 | NM_001018024.3 | c.41T>C | p.Ile14Thr | missense_variant | 2/3 | ENST00000369484.8 | NP_001018024.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMC4 | ENST00000369484.8 | c.41T>C | p.Ile14Thr | missense_variant | 2/3 | 1 | NM_001018024.3 | ENSP00000358496.3 | ||
ENSG00000288258 | ENST00000504061.1 | n.*55T>C | non_coding_transcript_exon_variant | 2/3 | 3 | ENSP00000427132.1 | ||||
ENSG00000288258 | ENST00000504061.1 | n.*55T>C | 3_prime_UTR_variant | 2/3 | 3 | ENSP00000427132.1 | ||||
CMC4 | ENST00000369479.1 | c.41T>C | p.Ile14Thr | missense_variant | 2/3 | 3 | ENSP00000358491.1 |
Frequencies
GnomAD3 genomes AF: 0.0000710 AC: 8AN: 112631Hom.: 0 Cov.: 23 AF XY: 0.0000862 AC XY: 3AN XY: 34795
GnomAD3 genomes
AF:
AC:
8
AN:
112631
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34795
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000783 AC: 13AN: 166111Hom.: 0 AF XY: 0.0000719 AC XY: 4AN XY: 55617
GnomAD3 exomes
AF:
AC:
13
AN:
166111
Hom.:
AF XY:
AC XY:
4
AN XY:
55617
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000222 AC: 24AN: 1082883Hom.: 0 Cov.: 27 AF XY: 0.0000254 AC XY: 9AN XY: 353721
GnomAD4 exome
AF:
AC:
24
AN:
1082883
Hom.:
Cov.:
27
AF XY:
AC XY:
9
AN XY:
353721
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000710 AC: 8AN: 112631Hom.: 0 Cov.: 23 AF XY: 0.0000862 AC XY: 3AN XY: 34795
GnomAD4 genome
AF:
AC:
8
AN:
112631
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34795
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
14
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.41T>C (p.I14T) alteration is located in exon 2 (coding exon 1) of the CMC4 gene. This alteration results from a T to C substitution at nucleotide position 41, causing the isoleucine (I) at amino acid position 14 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at